-
A288912-5mgApplicationA-484954 has been used a selective and potent inhibitor to inhibit eEF2K (eukaryotic elongation factor 2 kinase), in order to check the enhancement of synaptic transmission in the stratum radiatum of the hippocampal CA1 region. It has
-
A288395-10mgHighly potent and competitive NPRA antagonist.
-
A288395-1mgHighly potent and competitive NPRA antagonist.
-
A288395-25mgHighly potent and competitive NPRA antagonist.
-
A288395-5mgHighly potent and competitive NPRA antagonist.
-
A288900-100mgPotent inhibitor of TGF-βRI.
-
A288900-10mgPotent inhibitor of TGF-βRI.
-
A288900-200mgPotent inhibitor of TGF-βRI.
-
A288900-25mgPotent inhibitor of TGF-βRI.
-
A288900-500mgPotent inhibitor of TGF-βRI.
-
A288900-50mgPotent inhibitor of TGF-βRI.
-
A288900-5mgPotent inhibitor of TGF-βRI.